Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response. (Q36184227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ann F. Chambers

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Robert G. Bristow

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

J W Thoms

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Dal Pra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

P H Anborgh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

E Christensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

N Fleshner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C Menard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

K Chadwick

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C Catton

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

M Pintilie

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

7 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

840-846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

Abiraterone and increased survival in metastatic prostate cancer

10 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Pre- and post-translational regulation of osteopontin in cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Small integrin-binding proteins as serum markers for prostate cancer detection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Role of osteopontin in tumour progression

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Osteopontin is a marker for cancer aggressiveness and patient survival

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

REporting recommendations for tumor MARKer prognostic studies (REMARK).

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Prostate cancer--testing, incidence, surgery and mortality.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425969

Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.345

Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.345

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

21 January 2018

1 reference

12 December 2020

Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer

1 reference

12 December 2020

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer

1 reference

12 December 2020

IMRT and molecular biological approaches in radiotherapy for prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

22871886

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22871886%20AND%20SRC:MED&resulttype=core&format=json